Abstract
Background
To report the neuro-ophthalmological findings in the TAFRO syndrome in a South American patient.
Methods
This is a case report of a patient with TAFRO syndrome.
Results
We present the case of a 66-year-old woman with TAFRO syndrome and multicentric Castleman disease, who developed ophthalmic manifestations, as a rare complication, including optic disk edema and serous retinal detachment, which improved with conventional therapy.
Conclusions
The optic disk edema could be present as a neuro-ophthalmological finding in TAFRO syndrome. To the best of our knowledge, this is the first report on the ophthalmic manifestations in the TAFRO syndrome.
This is a preview of subscription content, access via your institution.
References
- 1.
Takai K, Nikkuni K, Shibuya H, Hashidate H (2010) Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly. Rinsho Ketsueki 51(5):320–325
- 2.
Masaki Y, Kawabata H, Takai K, Kojima M, Tsukamoto N, Ishigaki Y et al (2016) Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version. Int J Hematol 103(6):686–692
- 3.
Yasuda S, Tanaka K, Ichikawa A, Watanabe K, Uchida E, Yamamoto M et al (2016) Aggressive TAFRO syndrome with reversible cardiomyopathy successfully treated with combination chemotherapy. Int J Hematol 104(4):512–518
- 4.
Simons M, Apor E, Butera JN, Treaba DO (2016) TAFRO syndrome associated with EBV and successful triple therapy treatment: case report and review of the literature. Case Rep Hematol 2016:4703608
- 5.
Kawabata H, Takai K, Kojima M, Nakamura N, Aoki S, Nakamura S et al (2013) Castleman-Kojima disease (TAFRO syndrome): a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly: a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012). J Clin Exp Hematop 53(1):57–61
- 6.
Tedesco S, Postacchini L, Manfredi L, Goteri G, Luchetti MM, Festa A et al (2015) Successful treatment of a Caucasian case of multifocal Castleman’s disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report. Exp Hematol Oncol 4(1):3
- 7.
Abdo LA, Morin CP, Collarino RP, Cabane JP, Gatfosse MA (2014) First European case of TAFRO syndrome associated with Sjogren disease. Am J Intern Med 2(6):102–105
- 8.
Contardo D, Finocchietto P, Uehara T, Papini C, Deligiannis N, Darderes E et al (2015) TAFRO syndrome in a patient of south-american descent. EJCRIM. doi:10.12890/2015_000220
- 9.
Castleman B, Iverson L, Menendez VP (1956) Localized mediastinal lymph node hyperplasia resembling thymoma. Cancer 9(4):822–830
- 10.
Allegra A, Rotondo F, Russo S, Calabrò L, Maisano V, Bacci F et al (2015) Castleman-Kojima disease (TAFRO syndrome) in a Caucasian patient: a rare case report and review of the literature. Blood Cells Mol Dis 55(3):206–207
- 11.
Takasawa N, Sekiguchi Y, Takahashi T, Muryoi A, Satoh J, Sasaki T (2016) A case of TAFRO syndrome, a variant of multicentric Castleman’s disease, successfully treated with corticosteroid and cyclosporine A. Mod Rheumatol 14:1–5
- 12.
Iwaki N, Fajgenbaum DC, Nabel CS, Gion Y, Kondo E, Kawano M et al (2016) Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease. Am J Hematol 91(2):220–226
- 13.
Kumar S, Sharma S (2015) Polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes (POEMS syndrome): a paraneoplastic syndrome. Oxf Med Case Rep 3:237–240
- 14.
Carbone A, Pantanowitz L (2016) TAFRO syndrome: an atypical variant of KSHV-negative multicentric Castleman disease. Am J Hematol 91(2):171–172
- 15.
Masaki Y, Nakajima A, Iwao H, Kurose N, Sato T, Nakamura T et al (2013) Japanese variant of multicentric Castleman’s disease associated with serositis and thrombocytopenia—a report of two cases: is TAFRO syndrome (Castleman-Kojima disease) a distinct clinicopathological entity? J Clin Exp Hematop 53(1):79–85
- 16.
Kawashima M, Usui T, Okada H, Mori I, Yamauchi M, Ikeda T et al (2015) TAFRO syndrome: 2 cases and review of the literature. Mod Rheumatol 20:1–5
- 17.
Kojima M, Nakamura N, Otuski Y, Itoh H, Ogawa Y, Kobayashi H et al (2008) Pulmonary lesion of idiopathic plasmacytic lymphadenopathy with polyclonal hyperimmunoglobulinemia appears to be a cause of lymphoplasmacytic proliferation of the lung: a report of five cases. Pathol Res Pract 204(3):185–190
- 18.
Sakai K, Maeda T, Kuriyama A, Shimada N, Notohara K, Ueda Y (2016) TAFRO syndrome successfully treated with tocilizumab: a case report and systematic review. Mod Rheumatol 17:1–6
- 19.
Kourelis TV, Buadi FK, Kumar SK, Gertz MA, Lacy MQ, Dingli D et al (2016) Long-term outcome of patients with POEMS syndrome: an update of the Mayo Clinic experience. Am J Hematol 91(6):585–589
Author information
Affiliations
Corresponding author
Ethics declarations
Ethics approval
All the scientific and ethical principles of the Helsinki Declaration on Human Research were respected.
Consent for publication
Written informed consent was obtained from the patient for publication of this case report and any accompanying images.
Conflict of interest
The authors declare that there is no conflict of interest.
Funding
All the sources were provided by the authors.
Rights and permissions
About this article
Cite this article
Ortiz, A., Cárdenas, P., Peralta, M. et al. Neuro-ophthalmological findings in TAFRO syndrome in a patient from South America, a variant of multicentric Castleman’s disease. Int Ophthalmol 38, 1641–1646 (2018). https://doi.org/10.1007/s10792-017-0636-x
Received:
Accepted:
Published:
Issue Date:
Keywords
- Optic nerve disease
- Multicentric Castleman’s disease
- Electrophysiology
- Thrombocytopenia